Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations

Translated title of the contribution: Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations

C.T. de Kanter, J.P. Drenth, J.E. Arends, H.W. Reesink, M van der Valk, R.J. de Knegt, D.M. Burger

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations
Original language	Undefined/Unknown
Pages (from-to)	409-427
Number of pages	11
Journal	Clinical Pharmacokinetics
Volume	53
Issue number	5
DOIs	https://doi.org/10.1007/s40262-014-0142-5.
Publication status	Published - 2014

Access to Document

@article{f124b8afa827423ca7b05ec7eaeccf9f,

title = "Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations",

author = "\{de Kanter\}, C.T. and J.P. Drenth and J.E. Arends and H.W. Reesink and \{van der Valk\}, M and \{de Knegt\}, R.J. and D.M. Burger",

year = "2014",

doi = "10.1007/s40262-014-0142-5.",

language = "Undefined/Unknown",

volume = "53",

pages = "409--427",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "5",

}

TY - JOUR

T1 - Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations

AU - de Kanter, C.T.

AU - Drenth, J.P.

AU - Arends, J.E.

AU - Reesink, H.W.

AU - van der Valk, M

AU - de Knegt, R.J.

AU - Burger, D.M.

PY - 2014

Y1 - 2014

U2 - 10.1007/s40262-014-0142-5.

DO - 10.1007/s40262-014-0142-5.

M3 - Article

SN - 0312-5963

VL - 53

SP - 409

EP - 427

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 5

ER -